Related Experiment Videos
Iron acquisition and transport in Staphylococcus aureus
1Department of Microbiology, University of Chicago, CLSC Room 601, 920 E 58th Street, Chicago, IL, 60637, USA.
Summary
Staphylococcus aureus uses a cell-wall pathway called the iron-responsive surface determinant (isd) locus to acquire essential iron from hosts. This discovery offers new therapeutic targets against antibiotic-resistant bacteria.
Area of Science:
- Microbiology
- Bacterial Pathogenesis
- Molecular Biology
Background:
- Pathogenic bacteria must overcome host defenses for invasion.
- The bacterial cell wall plays crucial roles in both bacterial physiology and pathogenesis.
- Iron is an essential nutrient sequestered by host tissues, posing a challenge for invading bacteria.
Purpose of the Study:
- To review the molecular mechanisms of the iron-responsive surface determinant (isd) pathway in Staphylococcus aureus.
- To elucidate the role of the isd pathway in iron acquisition and bacterial pathogenesis.
- To explore the potential of the isd pathway as a therapeutic target against antimicrobial resistance.
Main Methods:
- Review of existing literature on the isd locus in Staphylococcus aureus.
- Analysis of the molecular components of the isd pathway, including membrane transporters and cell wall-anchored proteins.
- Emphasis on the mechanism of iron transport and its significance during infection.
Main Results:
- Identification of a novel cell-wall-based iron acquisition and import pathway in Staphylococcus aureus, the isd locus.
- The isd locus comprises a membrane transporter, heme-binding proteins, heme/haptoglobin receptors, heme oxygenases, and sortase B.
- This pathway demonstrates an additional critical function of the bacterial cell wall in pathogenesis.
Conclusions:
- The isd pathway is a key system for Staphylococcus aureus to acquire iron, essential for its survival and virulence.
- Understanding the isd pathway provides new insights into bacterial-host interactions.
- Targeting the isd pathway presents a promising strategy for developing novel therapeutics against drug-resistant Staphylococcus aureus infections.